What Can You Do About HAART Side Effects?
Trying to figure out how to alleviate the side effects of your HIV
meds? Wondering whether the health problem you're having is related
to HAART? HIV specialist Dr. Brian Conway has joined The Body's
amazing team of online experts and is now available to answer all
your questions about HIV treatment side effects. If there's
something on your mind, now's the perfect time to ask!
Where Poor HIV Care Lurks, Deadly Pneumonia Follows
Pneumocystis (also known as PCP) is still one of the leading causes
of death among people with HIV in some parts of the U.S., even
though it's very easily prevented. Statistics like these can show
where people are receiving access to medical care and where they
You Know You Need Help ... But How Do You Ask?
When you're used to being financially independent, it can be
excruciatingly hard to adjust if you reach the point where you
realize you need government assistance for your HIV care.
Psychologist Dr. J. Buzz von Ornsteiner has some advice for
anyone who's in this difficult position.
Updates on the Global AIDS Funding Front
U.S. President George W. Bush has signed into law a bill authorizing
the spending of up to $15 billion over the next five years to fund
HIV prevention and treatment programs in 12 African and two Caribbean
nations. However, political battles coupled with economic concerns
might sharply reduce the amount that's actually provided.
Congresswoman Nancy Pelosi of San Francisco is the U.S. House
Democratic leader and, according to top AIDS advocate John James,
the most informed member of Congress on AIDS. In recent remarks,
she commented briefly on the strengths and weaknesses of President Bush's global AIDS bill.
Thanks to increased pressure from AIDS advocates, African leaders,
the United Nations and the U.S., the European Union vowed last
weekend to spend $1 billion per year on the global fight against
HIV/AIDS. At a recent meeting of the Group of 8 major industrial
powers, France also announced it would triple its yearly contribution
to the Global Fund to 150 million euros (US$176.1 million).
How Much Are Your Meds? It Depends on Where You Live
A Wall Street Journal investigation showed major price variations
in some generic drugs in the U.S. John James reports on how you can
be sure you're getting the best price.
HIV/AIDS Vocabulary We Can All Understand
Sometimes HIV specialists, HIV caseworkers -- even some HIVers --
talk about the virus with words that seem impossible to understand:
"pharmacokinetics," "co-formulation," "sequencing." Here's a list of
some of the most often-used HIV-related terms and their definitions.
HIV in China: A Closer Look
A group of Chicago healthcare workers take an intimate look at the
prevention and treatment of HIV in China. "China now stands at a
crucial crossroads," they write. "The choices they make in the next
few years ... will determine the future of the entire country for
decades to come."
Dealing With Depression When You're HIV Positive
Depressed? Even for someone with HIV, depression is very treatable:
therapy, medications and alternative treatments are all options.
Click here for some more tips from PositiveWords.
Anti-HIV Meds May Help HIV, But Rarely
Treatment Action Group periodically scours the top medical journals
looking for the latest developments in HIV research. Click here to
see a review of its findings, which include the first evidence that,
in very rare cases, HIV could actually become dependent on an
anti-HIV drug for its survival.
Which Works Best: Viramune or Sustiva?
Does nevirapine (Viramune) = efavirenz (Sustiva) when used in
first-line treatment? Here's another look at the important 2NN
study, from Positively Aware.
A Selection of the Top HIV/AIDS Stories From Across the Internet:
A Farewell to a Patient Most Beloved
For almost 10 years, Dr. Abigail Zuger treated Mr. S. for AIDS. How their time together came to an end was something neither of them expected
From The New York Times (free registration required) (June 3, 2003)
The Bishop Who Took His Entire Family for HIV Test
A religious figure takes a bold step in a region where HIV stigma still rules the day
From East African Standard, Nairobi (June 2, 2003)
Efficacy of Enfuvirtide in Patients Infected With Drug-Resistant HIV-1 in Europe and Australia
The promising 24-week results from the TORO 2 study on T-20, also known by its brand name Fuzeon
From New England Journal of Medicine (May 29, 2003)
Mum's the Word for Some With HIV
A new study reports that more than 10 percent of American men and women who are HIV positive don't disclose their HIV status before having unprotected sex
From HealthScoutNews Reporter (May 29, 2003)
A Prospective Trial of Structured Treatment Interruptions in Human Immunodeficiency Virus Infection
Treatment cycling -- two weeks off treatment, eight weeks on -- largely fails to help HIVers develop a stronger immune response to HIV
From Archives of Internal Medicine (May 26, 2003)
Risk of HIV Infection Through Receptive Oral Sex
The bottom line: There's basically no risk, prominent HIV experts said during this interesting roundtable discussion
From HIV InSite (March 14, 2003)